Wednesday's top 4 stocks to watch include Apple, Pfizer, and more

Stocks were set for a higher open on Wednesday after a choppy start to the holiday-shortened week. With many players still on holiday and a general lack of catalysts, volume is likely to stay low. The following equities are recommended for Wednesday:

The quantity of iPhone 14 Pro shipments anticipated by Apple (NASDAQ:AAPL) in 2022 has been downgraded by Trendforce. According to the research company, 78.1 million units of the product were distributed during the year despite the tech giant experiencing a labour crisis in China. Additionally, Trendforce reduced its Q1 projection.

The U.S. Food and Drug Administration has accepted Pfizer's (PFE) pentavalent meningococcal vaccination candidate for study. In October 2023, the FDA is expected to rule on PFE's application.

According to a study conducted in Australia, the mRNA-based vaccinations outperform the protein-based COVID vaccine created by Novavax (NVAX). The New South Wales Ministry of Health supported the study, which discovered that individuals who received the NVX had higher rates of COVID infection than those who received competing vaccines.

The CEO of Maxeon Solar Technologies (MAXN), Bill Mulligan, has been named as an outside executive. Previously, Mulligan worked at Sila Nanotechnologies as its COO. Mark Babcock, the acting CEO, will thereafter resume his responsibilities as chief revenue officer.

See why Seeking Alpha contributor Avi Gilburt expects the S&P 500 to rise to 4,300 if the current support levels hold for more information on the general market.